Charles Schwab’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132M Buy
1,889,829
+302,233
+19% +$16.8M 0.02% 636
2026
Q1
$67.6M Buy
1,587,596
+252,952
+19% +$10.2M 0.01% 947
2025
Q4
$50M Buy
1,334,644
+237,637
+22% +$7.97M 0.01% 1165
2025
Q3
$32.4M Buy
1,097,007
+368,868
+51% +$8.57M 0.01% 1434
2025
Q2
$17.2M Buy
728,139
+233,908
+47% +$4.88M ﹤0.01% 1754
2025
Q1
$8.94M Buy
494,231
+43,238
+10% +$849K ﹤0.01% 2001
2024
Q4
$7.68M Buy
450,993
+10,658
+2% +$184K ﹤0.01% 2134
2024
Q3
$6.46M Buy
440,335
+6,326
+1% +$79.3K ﹤0.01% 2244
2024
Q2
$4.93M Buy
434,009
+6,311
+1% +$68.9K ﹤0.01% 2363
2024
Q1
$4.65M Buy
+427,698
New +$4.28M ﹤0.01% 2315

Other funds holding BTSG

Charles Schwab's BTSG Position: Q2 2026 in Review

Charles Schwab increased its BrightSpring Health Services (BTSG) stake by 19% in Q2 2026, buying an estimated $16.8M and bringing the position to 1,889,829 shares worth $132M. The position accounts for 0.02% of the portfolio, ranked #636.

Charles Schwab first reported a position in BTSG in Q1 2024 and has held it in 10 quarters since. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • Charles Schwab held 1,889,829 shares of BrightSpring Health Services worth $132M as of Q2 2026.
  • Charles Schwab bought 302,233 BrightSpring Health Services shares in Q2 2026, an estimated $16.8M.
  • BrightSpring Health Services made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #636 holding.
  • Charles Schwab first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 10 quarters since.
  • 423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.